home / stock / ngenf / ngenf news

NGENF News and Press, NervGen Pharma Corp From 11/19/20

Stock Information
Company Name: NervGen Pharma Corp
Stock Symbol: NGENF
Market: OTC
Website: nervgen.com
Menu
NGENF NGENF Quote NGENF Short NGENF News NGENF Articles NGENF Message Board
Get NGENF Alerts

News, Short Squeeze, Breakout and More Instantly...
NGENF - NervGen Pharma Reports Third Quarter 2020 Results and Provides Operational Update

Vancouver, British Columbia--(Newsfile Corp. - November 19, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today reported its...
NGENF - NervGen Pharma Retains Dr. George Perry to Advise on Alzheimer's Disease Program and Renews Business Advisory Relationship with Brian McAlister

Vancouver, British Columbia--(Newsfile Corp. - November 10, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced th...

NGENF - NervGen Pharma Appoints Randall E. Kaye, MD to the Board of Directors and Provides Operational Update

Vancouver, British Columbia--(Newsfile Corp. - October 28, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced tha...

NGENF - NervGen Pharma Engages Dr. Michael Davis, Former Director of the U.S. Combat Casualty Care Research Program, to Advise on Strategic Development Targets and Non-Dilutive Funding Sources For NVG-291

Vancouver, British Columbia--(Newsfile Corp. - October 19, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today is pleased to...
NGENF - NervGen Pharma Provides Company Update and Announces Results of Annual General Meeting of Shareholders

Vancouver, British Columbia--(Newsfile Corp. - October 1, 2020) -   NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, provided an up...

NGENF - NervGen Pharma Announces Annual General Meeting and Company Update to Be Held on September 30, 2020

Vancouver, British Columbia--(Newsfile Corp. - September 22, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced t...

NGENF - NervGen Pharma Announces Departure of Chief Operating Officer

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2020) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases, today announced tha...
NGENF - NervGen Pharma (NGENF) Investor Presentation - Slideshow

The following slide deck was published by NervGen Pharma Corp. in conjunction with this Read more ...

NGENF - (LD Micro) 360 Companies Set to Present this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

NGENF - NervGen Pharma reports Q2 results

NervGen Pharma ( OTCQX:NGENF ) : Q2 GAAP EPS of -$0.09. The net cash burn for Q2 2020 from operating activities was ~$1.4M. Cash balance of $3.5M Press Release More news on: NervGen Pharma Corp., Earnings news and commentary, Healthcare stocks news, ,

Previous 10 Next 10